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THE SPECIFICITY OF THE COMPLEMENT FIXATION TEST IN
POLIOMYELITIS* *
Infection with poliomyelitis virus gives rise to complement-fixing (C-F)
antibodies which may be detected with antigens prepared either from the
brains of infected mice or tissue culture fluids, as shown with Type II by
Casals et al."' and with all three types by Svedmyr et al.' These workers
used sufficient antigen in each test to obtain maximum sensitivity. With this
antigen concentration the presence of antibody could generally be detected
within the first week after onset of the disease, but the sera usually gave
similar C-F titers against antigens of the three types of poliomyelitis virus
regardless of the type involved in the infection. It has now been found
possible to obtain a more specific reaction in patients with the disease by a
method in which not more than one conventional unit of antigen is used
per test. In order to detect fixation with this low level of antigen, dilutions
of serum were titrated at several complement concentrations by the plate
method of Fulton and Dumbell.'
METHODS AND MATERIALS
The general technique of the plate C-F method as used in this laboratory
has been described previously.' This method has already been used in polio-
myelitis work by Svedmyr et al.,' and by Le Bouvier.! Instead of glass capil-
laries, the dropping pipettes used in this study consisted of No. 19 needles,
with the bevelled tip removed,' fitted to "oiling tubes."t The unit in which
complement was used was the greatest amount of freshly reconstituted,
lyophilized guinea pig serum in a 20-cm. drop that caused no visible
hemolysis in the test system. This "minimal unit" is approximately one-
third of a conventional 100%o lytic unit. Serum and antigen titrations were
carried out against two, three, and four of these units and the controls were
tested against one, two, and three units.
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Antigens were prepared from virus grown to high titer (106 to 108 TC5o
doses per ml.) in bottle-cultures of kidney tissue' and of HeLa cells.8* The
Brunhilde and W-S (Type I), Y-SK (Type II), and Leon (Type III)
strains were found to be satisfactory for the preparation of antigens. Fluids
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FIG. 1. Appearance of a typical plate at time of reading, and corresponding fixation
scores.
from the tissue cultures were harvested when most of the cells had lysed
(after 16 to 64 hours exposure to virus depending on the inoculum). These
fluids were lightly centrifuged to remove cellular debris and were generally
used without further treatment. The amount of antigen required to fix one
minimal unit of complement in excess of the greatest amount fixed by any
of the controls was termed one minimal unit. This is between one-half and
* Some of the HeLa bottle-cultures were obtained ready for use from Microbiologi-
cal Associates, Bethesda, Maryland.
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one-fourth of a conventional unit. Fluids containing less than two units per
20 cm. drop could be concentrated by centrifugation at 40,000 R.P.M.
(about 106,000 x gravity) for two hours, and resuspension of the pellet in
a small volume of diluent, but this was usually not necessary. Occasional
lots were found anticomplementary in which case they could often be made
serviceable by heating at 560 C. for 30 minutes.9 Heating the antigens had
the added advantage of rendering them non-infectious.
Sera were titrated with two minimal units of antigen per test drop against
three concentrations of complement. The titer of a serum was taken as the
highest dilution to fix more than one minimal unit of complement in excess
of the amount fixed by either serum or antigen control. (For example in
the Type I titration illustrated in Figure 1, the greater amount of fixation
is in the antigen control. The highest serum dilution to give fixation of
more than one unit in excess of this control is 1: 16 and the serum titer is
16.) As well as the titer, it was possible to determine from such a two-
dimensional titration, the total amount of complement fixed. This character
of the serum, its azndity for complement, is partially independent of the
titer. An expression of the avidity dependent on both the titer of the serum
and the amount of complement fixed was calculated as follows: (a) the
score for the degree of fixation was summed for all serum dilutions up to
the titration endpoint, and from this was subtracted (b) the number of
dilutions tested up to the endpoint, multiplied by the sum of the fixation
score for the control showing the greater degree of fixation. Serum scores,
(a) above, were calculated for the titrations with two, three, and four units
of complement and the control scores (b) for one, two, and three units and
thus the avidity was positive only when more than one unit of complement
was fixed. (In the Type I example again, the value for (a) is 22, and for
(b) the subtrahend, based on the antigen control, is 6 x 3 or 18. The avid-
ity score is therefore four. The avidity for the Type III titration in Figure
1 is ten, although the titer is only eight.) With the human sera the avidity
was found more reproducible and showed fewer erratic variations between
serial serum samples than the simple serum titer.
RESULTS
Standard monkey sera. Monkey sera prepared and kindly supplied by
Wenner et al.'0 were titrated in two-fold dilutions against various antigens
at several concentrations. The results are given in Table 1. The titers
obtained with the higher antigen concentrations were comparable to those
found in the laboratories of Wenner and of Enders, and the slight crossing
between the Type II serum and Type I antigen was confirmed.'0 The titers
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found when approximately two minimal units of antigens were usedc were
somewhat lower. Approximately two units were used in the studies on
human sera reported below.
TABLE 1. TITER OF STANDARD POLIOMYELITIS SERA AGAINST DIFFERENT
CONCENTRATIONS OF ANTIGENS
Antigens Titer of standard monkey sera
No. of
Virus Cell culture minimal
strain used units I II III
Brun. Kidney 3.5 >64 <4 <4
WS HeLa 3.0 32 <2 <2
Brun. Kidney 2.7 32 <2 <2
WS HeLa 2.1 32 <4 <4
Brun. Kidney 2.0 16 <2 <2
WS HeLa 1.5 32 <4 <4
Brun. Kidney 1.3 16 <2 <2
YSK Kidney 3.5 4 >64 <4
YSK HeLa 3.0 2 32 <2
YSK Kidney 2.7 tr* 16 <2
YSK HeLa 2.1 tr 16 <4
YSK Kidney 2.0 tr 8 <2
YSK HeLa 1.5 <8 <8 <4
YSK Kidney 1.3 tr 4 <2
Leon Kidney 4.0 <4 <4 >64
Leon Kidney 3.3 2 <2 64
Leon Kidney 2.5 <4 <4 32
Leon HeLa 2.0 .... <2 16
Leon Kidney 1.7 <8 <4 16
Leon HeLa 1.4 .... <2 16
Leon HeLa 1.0 .... <2 tr
* tr indicates trace (less than 2).
Sera from poliomyelitis patients.* Acute and convalescent sera from 49
patients diagnosed as poliomyelitic were tested for C-F antibodies against
the three types of antigen. These sera had previously been tested for neu-
* Material obtained from patients in the Lock Haven, Pennsylvania, epidemic of
1952. Detailed virological study in which Drs. Manuel Ramos Alverez and Anthony J.
Girardi actively participated will be presented in a separate paper.
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tralizing antibody, and stools from most of the patients had been tested for
virus."1 Both Type I and II viruses, but no Type III virus had been isolated
from the stools. Some examples of the results are given in Table 2, and the
TABLE 2. EXAMPLES OF DATA OBTAINED ON LOCK HAVEN CASES
Clini-
cal ezi-
dence
Type of of Date
Patient virus paral- of
no. isolated ysis serum*
83 I + 7
49
70
Complement fixation
Titers
I II III
0 0 16
32 0 4
32 0 0
Avidity
I II III
0 0 2
15 0 1
19 0 0
Neutralization
titers
I II III
160+ 20 0
160+ 40 0
160+ 160+ 0
93 II + 3 0 0 0 0 0 0 0 10 0
33 0 32 0 0 15 0 0 100+ 0
44 0 32 0 0 31 0 0 100+ 0
8 Neg. 3 0 0 0 0 00 100+
21 4 0 0 1 0 0 100+
50 16 0 0 7 0 0 100+
0 0
0 0
0 0
* Days after onset.
0 indicates less than 4.
32 indicates 32 or greater.
TABLE 3. SUMMARY OF RESPONSES IN C-F ANTIBODIES IN POLIOMYELITIS
PATIENTS
Type of virus isolated I I II II 0 0
Paralysis + - + - +
Antibody responses No. of patients in each category
Against one type 15 12 4 1 0 4
Against two types 3 0 1 0 0 0
Against three types 0 0 0 0 0 0
Against no type 0 1 1 2 2 3
types of response found in all the sera are classified in Table 3 by type of
disease. All patients from whom virus was isolated had homotypic neutral-
izing antibodies in their serum and frequently this was already at high titer
at the time of the first serum collection (0-14 days after onset), e.g. No. 83.
In contrast homotypic C-F antibodies were rarely detectable in the first
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serum sample by the method which has been described. Of the 40 patients
studied from whom virus was isolated only three (2 Type I, 1 Type II) had
demonstrable homotypic C-F antibodies at the time the first specimen was
collected, 0-14 days after onset. In six cases the antibodies first became
demonstrable in the third specimen more than 30 days after onset. More
heterotypic responses were found in the neutralizing than in the C-F anti-
bodies. There was no significant difference in the response of nonparalytic
and paralytic patients regardless of whether infected with Type I or II
viruses.
On the basis of the findings of Casals, Svedmyr, and their co-workers,2"
it was expected that the highest titers of C-F antibody would be found in
the sera collected in the first few weeks after onset. However, in the present
study homotypic C-F antibody was rarely found before seven days after the
onset of the disease and often increased after the third week. Because of
this it was possible to demonstrate an increase in titer more frequently than
might otherwise have been the case. On the other hand it was not possible
with this method to demonstrate such a rise until some weeks after the
individual had become sick.
The above investigators had found that many persons infected with Type
I poliomyelitis developed C-F antibodies against Type II antigen. Yet in
our study only one individual infected with Type I virus showed a Type II
C-F response, nor did the reverse heterologous response, Type I C-F anti-
bodies in Type II infection, occur more frequently. These differences be-
tween the results of our own studies and those from the two other labora-
tories appear to be due to the smaller amounts of antigen used in the
present work. Casals used 8 to 16 units of antigen in each test and Svedmyr
an approximately equivalent amount, whereas the amount of antigen used
in our study was not more than one conventional unit. Serum samples from
poliomyelitis patients have been exchanged with Dr. John F. Enders and
the results obtained by the method described in the present report proved
more specific than those obtained with concentrated antigens.!
Sera from children inoculated with formalinized Type I virus. The details
of this experiment"' will be reported elsewhere; here we merely wish to call
attention to the application of the complement fixation test to this type of
investigation. Thirty apparently healthy children aged 12 to 17 were tested
for C-F antibodies at the time of inoculation and 3 and 20 weeks after
inoculation with a formalin-inactivated Type I virus preparation, similar to
that used by Salk.7 At the time of inoculation Type I C-F antibodies were
not present at a detectable level in any individual, and Types II and III
antibodies were each present in only one individual. The changes found are
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given in Tables 4 and 5. Where antibodies appeared, they reached a peak
titer of eight or greater in all but three instances. The responses in this
group occurred, with but three exceptions, only against those types with
which there had been previous experience as indicated by the neutralization
tests that had been made before inoculation. Two of the three exceptions
TABLE 4. CHANGES IN C-F ANTIBODIES IN CHILDREN
WITH TYPE I FORMALIN-INACTIVATED VIRUS
AFTER INOCULATION
Neutralizing Number
Type of antibodies prior without C-F C-F antibody response
antibodies to inoculation antibodies pre-inoc. positive negative
I 10 1 9
+ 20 8 12
II 15 1 14
+ 15 9 6
III - 13 1 12
+ 13 7 6
TABLE 5. CHANGES IN TYPES I AND II C-F ANTIBODIES IN CHILDREN
AFTER INOCULATION WITH TYPE I FORMALIZED VACCINE
Result of
neutralization,
tests made Increased Increased
prior to inoc. Total number II I I and II Both
Type I Type II of cases Negative* Negative Increased negative
- - 7 0 0 1 6
+ 8 4 0 0 4
+ 3 0 2 0 1
+ + 12 1 4 3 4
T o t a l 30 5 6 4 15
* Negative indicates serum titer of less than 2.
occurred in one individual where Types I and II antibodies appeared in the
20-week sample. The findings in healthy children inoculated with formalin
inactivated virus were in marked contrast to those in poliomyelitic
patients reported above. In the latter the response was usually only
homotypic with the type of virus causing the infection. In the "vaccine"
study where all the responses were caused by Type I virus material the
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antibodies to the three types of virus responded similarly. The Type III
response was somewhat weaker than the Types I and II reaching lower
maximal titers (median for Type III was 8; for Types I and II, 32) and
falling off more rapidly. Table 5 shows that the presence of Type I neutral-
izing antibody had no significant effect on the probability of a Type II C-F
response and vice versa. The Type III C-F response was also independent
of Types I and II neutralizing antibodies, and Types I and II C-F responses
of Type III neutralizing antibodies, but to have included these combinations
would have overburdened the table. The reason for the contrasting non-
specificity of the response in the group of children in whom antibodies were
stimulated artificially as compared to the response in the natural infections,
has not been found as yet.
SUMMARY
A complement fixation test for poliomyelitis which uses minimal quanti-
ties of complement and antigen has been described and its application noted
in two phases of poliomyelitis investigations: serodiagnosis of infection and
antibody response to "vaccination": (i) Results of tests for C-F antibodies
for the three types of virus are reported on specimens obtained from 49
poliomyelitis patients. The results show a homotypic C-F titer r-ise in 90%
of the patients from whom virus was isolated, and a heterotypic rise in 10%.
(ii) Sera from 30 children before and after inoculation with formalin-
inactivated Type I virus were tested for C-F antibodies. Of these, 60%o
showed a post-inoculation increase in Type I, II, or III antibodies. Some
showed C-F responses to antibodies of more than one type. Nearly all
of the increases occurred in individuals who possessed pre-inoculation
neutralizing antibodies.
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